Weight Loss Injection Treatment – How Does It Work?

What Is Weight Loss Injection Treatment?

Weight loss injection treatment refers to the use of specific, scientifically proven medications designed to help individuals with overweight or obesity reduce their body weight and improve their metabolic health.

These are prescription-based medications, meaning they cannot be bought over the counter. They require a thorough medical evaluation by a licensed healthcare provider to ensure they are safe and appropriate for your specific biological needs. These medications are approved and regulated by relevant national and European regulatory authorities to ensure safety, efficacy, and compliance with legal standards. As part of the prescription process, your medical history will be carefully reviewed to determine if weight loss injection treatment is suitable for you. Prescribing follows national standards for health and care excellence, ensuring high-quality and safe care.

The medication is administered as a subcutaneous injection. This means it is injected into the fatty tissue just under the skin—usually in the abdomen, thigh, or upper arm—using a very small, thin needle in a pre-filled pen. While the idea of self-injecting may sound intimidating at first, the devices are designed to be extremely user-friendly and virtually painless.

It is important to understand that these injections are not meant for cosmetic use or quick-fixes. Weight loss medication should always be used in combination with structured lifestyle changes to achieve and maintain clinically meaningful weight loss. They are medical treatments aimed at addressing obesity as a complex, chronic disease characterized by hormonal imbalances and metabolic dysfunction.

How Do Weight Loss Injections Work in the Body?

To understand how these treatments work, we must look at how the body naturally signals hunger and fullness. The human body produces hormones in the gut after we eat, which travel to the brain to signal that we have had enough food. However, in people living with obesity, these signaling pathways are often disrupted.

Weight loss injections work by addressing these biological imbalances directly. Here is a simple breakdown of the core mechanisms:

• Influence appetite-regulating hormones: Semaglutide-based medications, including Wegovy (approved for obesity) and Ozempic (approved for type 2 diabetes), act on GLP-1 receptors in the appetite-regulating centers of the brain. Tirzepatide (Mounjaro) is a dual GIP and GLP-1 receptor agonist.

• Increase satiety: By strengthening these hormonal signals, the medication helps you feel full much faster when eating, allowing you to be satisfied with smaller portions. GLP-1 agonists mimic a hormone released after eating, which helps to lower appetite and increase feelings of fullness.

• Reduce hunger signals: The treatment actively reduces appetite, hunger signals, and “food noise”—the constant, intrusive thoughts and cravings for food, especially items high in fat and sugar.

• Support metabolic regulation: The injections slow down gastric emptying, meaning food stays in your stomach for a longer period. This not only prolongs the feeling of fullness but also helps stabilize and lower blood sugar levels after a meal, preventing sharp spikes and crashes that often trigger cravings.

What Types of Injectable Treatments Are Used?

Mounjaro (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide) are the three weight-loss injections commonly available on prescription across the European Union.

The landscape of medical weight management in the EU has expanded rapidly, with several advanced options now available. Most modern, highly effective injectables fall into the category of incretin mimetics. In clinical trials, target maintenance doses are often used to evaluate maximal efficacy, although in clinical practice dosing is individualized based on response and tolerability.

GLP-1 Based Treatments

The most common and widely studied injectable treatments are GLP-1 (Glucagon-Like Peptide-1) receptor agonists. Natural GLP-1 hormones produced by the body are broken down in a matter of minutes. The medication versions, however, are chemically modified to resist rapid breakdown, allowing them to stay active in your system for days or even a full week, providing continuous appetite control.

Differences Between Available Options

There are different active substances used in modern weight loss injections. The two most prominent are:

• Semaglutide-based medications such as Wegovy (approved for obesity) and Ozempic (approved for type 2 diabetes): A GLP-1 receptor agonist that targets one specific hormonal pathway. It is highly effective and widely used globally for both weight management and type 2 diabetes. Wegovy (semaglutide) is prescribed for individuals with a BMI of 30 or more, or 27 or more with at least one weight-related health issue.

• Tirzepatide (Mounjaro): A newer medication classified as a dual-agonist. It targets two hormonal pathways simultaneously (GLP-1 and GIP), which studies suggest may offer enhanced metabolic regulation. Mounjaro is prescribed for individuals with a BMI of 30 or more, or 27 or more with at least one weight-related health issue.

Treatment with these medications often begins with a lower dose to minimize side effects and is gradually increased as your body adjusts. If side effects are severe or persistent, it is important to consult a doctor for possible dose adjustment or discontinuation. Regular follow-ups with your healthcare provider are necessary to monitor your progress and adjust treatment as needed.

Safety of Weight Loss Injections

Weight loss injections, including well-known options like tirzepatide (Mounjaro) and semaglutide (Wegovy), have significantly expanded treatment options for obesity and type 2 diabetes by offering a clinically proven way to help you lose weight and improve your overall health. These prescription weight loss medications work by mimicking natural hormones that regulate appetite, making it easier to eat less food and feel satisfied with a reduced calorie diet.

When it comes to safety, weight loss injections are generally well-tolerated. The most common side effects include mild gastrointestinal symptoms such as nausea, constipation, diarrhea, and headache. These effects are usually temporary and can often be managed by adjusting the dose or following your healthcare professional’s advice. However, weight loss injections are not suitable for everyone. Individuals with certain health conditions – such as a history of pancreatitis or other specific medical histories – may not be eligible for this type of prescription weight loss treatment. That’s why a thorough assessment by a healthcare professional is essential before starting any weight loss medicine.

Ongoing support from a specialist weight management service, such as individualised medical weight loss help, is key to ensuring that weight loss injections work safely and effectively. Regular monitoring of your body weight, blood pressure, and other health markers allows your healthcare team to tailor your treatment plan, adjust your maintenance dose, and address any side effects promptly. This comprehensive approach helps support weight loss while safeguarding your overall wellbeing.

In addition to promoting weight loss, these injections may contribute to improvement and, in some cases, remission of certain weight-related comorbidities, particularly when substantial weight loss is achieved.

Ultimately, weight loss injections are a safe and effective option for many adults struggling with excess weight. When combined with healthy lifestyle changes, a balanced diet, and regular physical activity, they can help you lose weight, improve your health, and reduce your risk of future health conditions. Always consult with a healthcare professional alongside programmes like Yazen’s digital weight loss service to ensure you receive the best possible care on your weight loss journey.

How Much Weight Can You Lose?

In clinical trials, average weight reductions ranged from approximately 15% with semaglutide to over 20% with higher-dose tirzepatide in selected populations. This level of weight loss can have a profound impact on weight related health conditions, such as high blood pressure, abnormal blood fats, obstructive sleep apnoea, and cardiovascular disease. By helping you achieve and maintain a healthy weight, these treatments can also lower your risk of developing serious health problems linked to excess weight.

Clinical data from Yazen indicate that a substantial proportion of patients achieve clinically meaningful weight loss when combining medication with multidisciplinary support.

The amount of weight you lose depends on several factors, including your starting weight, genetics, and adherence to the medication schedule. Most importantly, the medication works best with lifestyle support. The injection acts as a tool that makes it significantly easier to maintain a caloric deficit without suffering from overwhelming hunger. However, sustainable weight loss still requires adopting healthier eating habits and engaging in regular physical activity.

At Yazen, we emphasize that medical weight loss requires continuous medical follow-up. We use the principle of the lowest effective dose, adjusting your medication carefully to maximize weight loss while minimizing potential side effects. Because we track your body composition, we ensure you are losing fat rather than valuable muscle mass.

Summary

Weight loss injection treatment offers a medically supervised, effective approach to managing obesity and excess weight by mimicking natural hormones that regulate appetite and metabolism. Medications like tirzepatide (Mounjaro) and semaglutide (Wegovy) help reduce hunger, increase feelings of fullness, and support significant weight loss when combined with healthy lifestyle changes such as a balanced diet and regular physical activity.

These treatments are prescribed based on individual health assessments and are most effective when integrated with ongoing support from healthcare professionals and specialist weight management services. While generally safe, weight loss injections can have side effects and require careful medical monitoring. Ultimately, they provide a valuable tool in the comprehensive management of weight-related health conditions, improving overall wellbeing and reducing the risk of serious illnesses linked to obesity.

References

Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). The New England Journal of Medicine. 2021.
https://www.nejm.org/doi/full/10.1056/NEJMoa2032183

Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). The New England Journal of Medicine. 2022.
https://www.nejm.org/doi/full/10.1056/NEJMoa2206038

NICE (National Institute for Health and Care Excellence). Semaglutide for managing overweight and obesity. 2023.
https://www.nice.org.uk/guidance/ta875

European Medicines Agency (EMA). Wegovy EPAR – Product Information.
https://www.ema.europa.eu/en/medicines/human/EPAR/wegovy

European Medicines Agency (EMA). Mounjaro EPAR – Product Information.
https://www.ema.europa.eu/en/medicines/human/EPAR/mounjaro

‍